Jeff Patton, MD, CEO, OneOncology, chairman of the board, Tennessee Oncology, discusses what audience members should expect from the Community Oncology Conference 2021 and sessions he is looking forward to.
Jeff Patton, MD, CEO of OneOncology and chairman of the board for Tennessee Oncology, discusses the Community Oncology Conference during its second year in a virtual format.
Transcript:
Heading into the second year of a virtual format for the Community Oncology Conference, how will this year’s layout compare to last year’s and what should audience members expect?
I think it'll be very similar. We got very good feedback on the format last year of going from live, to virtual. And so we're trying to recreate what it's like to be in person, which is hard, but I think we did a good job. The key aspect will be the same that we’ll continue to have 4 tracks, there'll be a clinical track, a business track, a pharmacy track, and an advocacy track.
The advantage of this format, quite frankly, is it's easier to switch from track to track and kind of see what you want to see. So, I highly encourage, as I always do, for non-clinical people to look at the clinical track and non-business folks to see what's going on in business down the line. The disadvantage, obviously, is missing the incredible networking opportunity, in which this is the best networking community oncology conference in the country. So, we will miss that.
What should the audience expect this year? This remains the penultimate community oncology conference, I said that before. I encourage every year anyone from Tennessee Oncology, and now everyone from OneOncology, if you can log on or participate in only one conference a year, this is the one.
As co-chair of this year’s conference, what discussions or sessions are you looking forward to most?
This is a little my bias—I'm introducing a Ronny Gal, a senior analyst from Bernstein, who will talk about the hospital transparency requirement that the government required starting in January. We've known for years that the hospitals have been overcharging for drugs and now that we have transparency, this is the biggest opportunity community oncology has had in 20 years to show that we are the high-quality, low-cost provider because they mark up drugs 250% and we certainly can't do that.
On the clinical side, all of them. I mean, it's fantastic. I guess the one that's near and dear to me is the immuno-oncology update, not just because my colleague David Spigel, MD, is doing it. He'll be introduced by my friend [Stephen "Fred" Divers, MD], and Tony Abraham[, DO MPA] will be on that as well.
On the pharmacy side, the PBM and payer update will be fascinating. We get a superstar cast there with John Levitt from Frier Levitt, our own Ted Okon, Rich Ingram[, MD], and Stuart Genschaw[, MHA, MBA]. So, all the games and tricks that the PBMs and insurers play—I would encourage attendance at that one.
And then I always enjoy the legislative update. Once again, an all-star cast: Ted Okon will moderate; Christian Downs[, JD, MHA] from [Association of Community Cancer Centers] will be there; Ben Jones from the US Oncology Network who I know is fantastic; Deborah Kamin[, RN, PhD,] who's from [American Society of Clinical Oncology], is great; Rebecca McGrath; and Brent Tallamy. So, this is always good and that's an all-star cast there.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More